Kidney transplant study to predict long-term health
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks at kidney transplant patients to better predict long-term outcomes by examining small samples of kidney tissue (biopsies). It may help doctors understand why some transplants succeed and others don't, potentially improving care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have had a kidney transplant (from a living or deceased donor).
- You must be able to understand and sign a consent form.
- You must not be taking long-term blood thinners or have a low platelet count (below 100,000).
- Your kidney failure must not have been caused by hemolytic uremic syndrome (HUS), a rare blood disorder.
- You must be on standard anti-rejection medicines (like tacrolimus and mycophenolate).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes of people who have had or will have a kidney transplant. It aims to learn how genetic information might help improve transplant care over time. Participants will give blood, urine, stool, and possibly kidney tissue samples for research.
This study looks at kidney tissue from patients having a liver transplant to understand and improve treatment for a kidney problem called hepatorenal syndrome. It may help doctors find better ways to protect kidney function after transplant.
This study looks at how the immune system reacts in kidney transplant patients who may be experiencing rejection. It aims to better understand and improve treatment for transplant rejection.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study is for people with a kidney transplant who are in the hospital for a biopsy because their doctor suspects rejection. Researchers want to see if a simple blood or urine test can detect rejection, which might make future biopsies less necessary.
This study looks at tissue samples from kidney transplant patients who have a specific type of long-term rejection called chronic active humoral rejection (cAMR). It aims to better understand the condition and help future patients.
Hear when a new Renal Transplant Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.